Role of apolipoprotein E variants in lipoprotein glomerulopathy and other renal lipidoses

[1]  H. Sasano,et al.  Significance of fat stains in serial sections from Epon-embedded tissue samples for electron microscopy in renal diseases , 2001, Clinical and Experimental Nephrology.

[2]  I. Sakata,et al.  Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity. , 2001, Kidney international.

[3]  W. März,et al.  Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy. , 2001, Journal of the American Society of Nephrology : JASN.

[4]  T. Ohno,et al.  A newborn infant with lipoprotein glomerulopathy associated with congenital nephrotic syndrome , 2001, Pediatrics international : official journal of the Japan Pediatric Society.

[5]  S. Hadjadj,et al.  Lack of relationship in long‐term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein ε, lipoprotein lipase and cholesteryl ester transfer protein , 2000 .

[6]  M. Polenaković,et al.  New Cases of Lipoprotein Glomerulopathy? , 2000, Nephron.

[7]  D. Moczulski,et al.  APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. , 2000, Diabetes.

[8]  M. Taskinen,et al.  Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients , 2000, Diabetologia.

[9]  Takashi Suzuki,et al.  Virus-mediated Transduction of Apolipoprotein E (ApoE)-Sendai Develops Lipoprotein Glomerulopathy in ApoE-deficient Mice* , 2000, The Journal of Biological Chemistry.

[10]  H. Parving,et al.  Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  K. Maruyama,et al.  A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy , 2000, Pediatric Nephrology.

[12]  T. Saruta,et al.  Association of a Novel 3-Amino Acid Deletion Mutation of Apolipoprotein E (Apo E Tokyo) with Lipoprotein Glomerulopathy , 1999, Nephron.

[13]  J. Sasaki,et al.  Lipoprotein Glomerulopathy: Renal Lipidosis Induced by Novel Apolipoprotein E Variants , 1999, Nephron.

[14]  N. Yorioka,et al.  Apolipoprotein E Polymorphism in IgA Nephropathy , 1999, Nephron.

[15]  J. Sasaki,et al.  A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy. , 1999, Kidney international.

[16]  T. Kita,et al.  A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. , 1999, Kidney international.

[17]  J. Sasaki,et al.  Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features. , 1999, Kidney international. Supplement.

[18]  N. Yorioka,et al.  Apolipoprotein E polymorphism and renal disease. , 1999, Kidney international. Supplement.

[19]  M. Nangaku,et al.  Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney. , 1999, Journal of the American Society of Nephrology : JASN.

[20]  Bozhang,et al.  Possible Induction of Renal Dysfunction in Patients With Lecithin:Cholesterol Acyltransferase Deficiency by Oxidized Phosphatidylcholine in Glomeruli , 1999 .

[21]  A. Djamali,et al.  Lipoprotein glomerulopathy: a new cause of nephrotic syndrome after renal transplantation. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  D. Tarng,et al.  Association of Apolipoprotein E Polymorphism with Lipoprotein Glomerulopathy , 1998, Nephron.

[23]  J. Todd,et al.  Association of Apolipoprotein ε2 Allele With Diabetic Nephropathy in Caucasian Subjects With IDDM , 1998, Diabetes.

[24]  M. Bewick,et al.  Recurrence of lipoprotein glomerulopathy after renal transplantation. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  S. Oikawa,et al.  Lipoprotein glomerulopathy and its pathogenesis. , 1997, Contributions to nephrology.

[26]  J. Sasaki,et al.  Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy. , 1997, Journal of the American Society of Nephrology : JASN.

[27]  R. Lifton,et al.  Lipoprotein glomerulopathy: a new role for apolipoprotein E? , 1997, Journal of the American Society of Nephrology : JASN.

[28]  K. Maruyama,et al.  Lipoprotein glomerulopathy: a pediatric case report , 1997, Pediatric nephrology (Berlin, West).

[29]  T. Saito.  Abnormal lipid metabolism and renal disorders. , 1997, The Tohoku journal of experimental medicine.

[30]  J. Niall,et al.  Glomerular lipid deposition and proteinuria in a patient with familial dysbetalipoproteinaemia , 1996, Journal of internal medicine.

[31]  A. Krolewski,et al.  Apolipoprotein E genotypes and risk of diabetic nephropathy. , 1996, Journal of the American Society of Nephrology : JASN.

[32]  T. Orchard,et al.  Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity. , 1995, Journal of the American Society of Nephrology : JASN.

[33]  T. Kita,et al.  Lipoprotein glomerulopathy with a new apolipoprotein E phenotype. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  A. Meyrier,et al.  Lipoprotein glomerulopathy: first case in a white European. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  S. Oikawa,et al.  Lipoprotein glomerulopathy: A new aspect of lipid induced glomerular injury , 1995 .

[36]  M. Eto,et al.  Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy. , 1995, Clinical genetics.

[37]  A. Kumar,et al.  Lipoprotein glomerulopathy: first report in a Chinese male. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  M. Haneda,et al.  A case of lipoprotein glomerulopathy successfully treated with probucol. , 1994, Nephron.

[39]  S. Oikawa,et al.  Lipoprotein glomerulopathy. Report of a normolipidemic case and review of the literature. , 1993, American journal of nephrology.

[40]  S. Oikawa,et al.  Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[41]  N. Kaneko,et al.  A Case of Lipoprotein Glomerulopathy: Light and Electron Microscopic Observations of the Glomerulus , 1990, Acta pathologica japonica.

[42]  M. Shichiri,et al.  Effect of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus , 1990 .

[43]  T. Sato,et al.  Apolipoprotein-E2 and hyperlipoproteinemia in noninsulin-dependent diabetes mellitus. , 1989, The Journal of clinical endocrinology and metabolism.

[44]  S. Matsuo,et al.  A case of nephrotic syndrome with glomerular lipoprotein deposition with capillary ballooning and mesangiolysis. , 1989, Nephron.

[45]  T. Tomita,et al.  [A case of nephrotic syndrome with a peculiar glomerular lesion]. , 1989, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[46]  S. Oikawa,et al.  Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[48]  T. Faraggiana,et al.  Renal lipidoses: a review. , 1987, Human pathology.

[49]  H. Holloway,et al.  A comparison of standard lipid staining techniques used in electron microscopic studies of mammalian tissues. , 1984, Stain technology.

[50]  R. Glassock,et al.  Renal disease : classification and atlas , 1987 .

[51]  E. Gjone.  Familial lecithin:cholesterol acyltransferase deficiency - a new metabolic disease with renal involvement. , 1981, Advances in nephrology from the Necker Hospital.

[52]  G. Hutchins,et al.  Type 3 hyperlipoproteinemia with mesangial foam cells in renal glomeruli. , 1974, Archives of pathology.

[53]  E. Korn,et al.  3. Modification of oleic acid during fixation of Amoebae by osmium tetroxide. , 1966, Biochimica et biophysica acta.